The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation

BACKGROUND: Lung cancer is the most frequently diagnosed malignant tumor and the highest mortality worldwide, and can be divided into two differential histologic subtypes, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). However, there are significant differences in diagnosis an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Yi, Li, Dong, He, Muqun, Wang, Jianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459535/
https://www.ncbi.nlm.nih.gov/pubmed/36093542
http://dx.doi.org/10.21037/tcr-22-245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459535/
https://www.ncbi.nlm.nih.gov/pubmed/36093542
http://dx.doi.org/10.21037/tcr-22-245

Ejemplares similares